These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10226237)

  • 1. The white-coat effect in treated hypertension.
    Myers MG
    Blood Press Monit; 1996 Jun; 1(3):247-249. PubMed ID: 10226237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
    Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
    Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated office blood pressure controls reduce the prevalence of white-coat hypertension and detect a group of white-coat normotensive patients.
    Fogari R; Corradi L; Zoppi A; Lusardi P; Poletti L
    Blood Press Monit; 1996 Feb; 1(1):51-54. PubMed ID: 10226202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
    Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors for the white coat effect in general practice patients with suspected and treated hypertension.
    Lindbaek M; Sandvik E; Liodden K; Mjell J; Ravnsborg-Gjertsen K
    Br J Gen Pract; 2003 Oct; 53(495):790-3. PubMed ID: 14601355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and predictors of white-coat response in patients with treated hypertension.
    MacDonald MB; Laing GP; Wilson MP; Wilson TW
    CMAJ; 1999 Aug; 161(3):265-9. PubMed ID: 10463047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between body-mass index and white-coat hypertension among referred patients.
    Ben-Dov IZ; Mekler J; Ben-Arie L; Bursztyn M
    Blood Press Monit; 2007 Apr; 12(2):95-9. PubMed ID: 17353652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the white-coat effect at multiple visits before and during treatment.
    Verberk WJ; Kroon AA; Thien T; Lenders JW; van Montfrans GA; Smit AJ; de Leeuw PW
    J Hypertens; 2006 Dec; 24(12):2357-63. PubMed ID: 17082716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of antihypertensive treatment with dihydropyridine calcium antagonists on white-coat hypertension.
    Høegholm A; Wiinberg N; Kristensen KS
    Blood Press Monit; 1996 Aug; 1(4):375-380. PubMed ID: 10226262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory blood pressure monitoring in treated hypertensive patients--implications for clinical practice.
    Myers MG
    J Hum Hypertens; 1996 Feb; 10 Suppl 2():527-31. PubMed ID: 8868041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White coat effect, blood pressure and mortality in men: prospective cohort study.
    Strandberg TE; Salomaa V
    Eur Heart J; 2000 Oct; 21(20):1714-8. PubMed ID: 11032699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?].
    Mozdzan M; Ruxer J; Barański M; Roszczyk N; Markuszewski L
    Ann Acad Med Stetin; 2008; 54(1):65-9; discussion 69. PubMed ID: 19127812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ambulatory blood pressure monitoring to study white coat syndrome in patients with hypertension seen in primary care].
    Villalba Alcalá F; Lapetra Peralta J; Mayoral Sánchez E; Espino Montoro A; Cayuela Domínguez A; López Chozas JM
    Rev Esp Cardiol; 2004 Jul; 57(7):652-60. PubMed ID: 15274850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulse pressure is more susceptible to the white coat effect than is systolic blood pressure: observations from real-life ambulatory blood pressure monitoring.
    Ben-Dov IZ; Perk G; Ben-Arie L; Mekler J; Bursztyn M
    Am J Hypertens; 2004 Jun; 17(6):535-9. PubMed ID: 15177528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White coat effect and white coat hypertension in pediatric patients.
    Matsuoka S; Kawamura K; Honda M; Awazu M
    Pediatr Nephrol; 2002 Nov; 17(11):950-3. PubMed ID: 12432440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between continuous ambulatory arterial blood pressure monitoring and standard blood pressure measurements among patients of younger and older age group.
    Babić BK; Bagatin J; Kokić S; Ostojić SB; Carević V; Berović N
    Coll Antropol; 2009 Mar; 33(1):65-70. PubMed ID: 19408605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White coat hypertension in Zimbabwean African women.
    Bhagat K
    East Afr Med J; 2000 Aug; 77(8):452-5. PubMed ID: 12862073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The "white coat effect" in hypertensive patients].
    Alföldi S; Járai Z; Monos E; Farsang C
    Orv Hetil; 1991 Jul; 132(27):1469-72. PubMed ID: 1956676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring.
    Ben-Dov IZ; Ben-Arie L; Mekler J; Bursztyn M
    Int J Cardiol; 2007 May; 117(3):355-9. PubMed ID: 16879886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.